Fos family members induce cell cycle entry by activating cyclin D1

Molecular and Cellular Biology

Volumn 18, Issue 9, 1998, Pages 5609-5619

  Brown, Jennifer R ^a,b   Nigh, Elizabeth ^a,b   Lee, Richard J ^c   Ye, Hong ^a,b   Thompson, Margaret A ^a,b   Saudou, Frederic ^a,b   Pestell, Richard G ^c   Greenberg, Michael E ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; TRANSCRIPTION FACTOR;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DNA SYNTHESIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; ONCOGENE C FOS; PRIORITY JOURNAL; PROTO ONCOGENE; TARGET CELL;

RODENTIA;

EID: 0031865948     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.9.5609     Document Type: Article

References (48)

1. Aktas, H., H. Cai, and G. M. Cooper. 1997. Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol. Cell. Biol. 17:3850-3857.
2. Albanese, C., J. Johnson, G. Watanabe, N. Eklund, D. Vu, A. Arnold, and R. G. Pestell. 1995. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270: 23589-23597.
3. Brown, J. R., H. Ye, R. T. Bronson, P. Dikkes, and M. E. Greenberg. 1996. A defect in nurturing in mice lacking the immediate early gene fosB. Cell 86:297-309.
4. Bruesselbach, S., U. Moehle-Steinlein, Z.-Q. Wang, M. Schreiber, F. C. Lucibello, R. Mueller, and E. F. Wagner. 1995. Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. Oncogene 10:79-86.
5. Busch, S. J., and P. Sassone-Corsi. 1990. Dimers, leucine zippers and DNA-binding domains. Trends Genet. 6:36-40.
6. Cherrington, J. M., and E. S. Mocarski. 1989. Human cytomegalovirus iel transactivates the α promoter-enhancer via an 18-base-pair repeat element. J. Virol. 63:1435-1440.
7. Curran, T., M. B. Gordon, K. L. Rubino, and L. C. Sambucetti. 1987. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2:79-84.
8. deSouza, S., J. Lochner, C. M. Machida, L. M. Matrisian, and G. Ciment 1995. A novel nerve growth factor-responsive element in the stromelysin-1 (transin) gene that is necessary and sufficient for gene expression in PC12 cells. J. Biol. Chem. 270:9106-9114.
9. Fantl, V., G. Stamp, A. Andrews, I. Rosewell, and C. Dickson. 1995. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9:2364-2372.
10. Field, S. J., R. S. Johnson, R. M. Mortensen, V. E. Papaioannou, B. M. Spiegelman, and M. E. Greenberg. 1992. Growth and differentiation of embryonic stem cells that lack an intact c-fos gene. Proc. Natl. Acad. Sci. USA 89:9306-9310.
11. Gius, D., X. Cao, F. J. Rauscher III, D. R. Cohen, T. Curran, and V. P. Sukhatme. 1990. Transcriptional activation and repression by Fos are independent functions: the C terminus represses immediate-early gene expression via CArG elements. Mol. Cell. Biol. 10:4243-4255.
12. Gruda, M. C., J. van Amsterdam, C. A. Rizzo, S. Durham, S. Lidra, and R. Bravo. 1996. Expression of FosB during mouse development: normal development of FosB knockout mice. Oncogene 12:2177-2185.
13. Hadman, M., M. Loo, and T. J. Bos. 1993. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences. Oncogene 8:1895-1903.
14. Hai, T., and T. Curran. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720-3724.
15. Herber, B., M. Truss, M. Beato, and R. Mueller. 1994. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9:1295-1304.
16. Herschman, H. R. 1991. Primary response genes induced by growth factors and tumor promoters. Annu. Rev. Biochem. 60:281-319.
17. Holt, J. T. 1986. Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc. Natl. Acad. Sci. USA 83:4794-4798.
18. Hu, E., E. Mueller, S. Oliviero, V. E. Papaioannou, R. Johnson, and B. M. Spiegelman. 1994. Targeted disruption of the c-fos gene demonstrates c-fos-dependent and -independent pathways for gene expression stimulated by growth factors or oncogenes. EMBO J. 13:3094-3103.
19. Jiang, W., S. M. Kahn, P. Zhou, Y.-J. Zhang, A. M. Cacace, A. S. Infante, S. Doi, R. M. Santella, and I. B. Weinstein. 1993. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene 8:3447-3457.
20. Johnson, R. S., B. M. Spiegelman, and V. Papaioannou. 1992. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71:577-586.
21. Kerr, L. D., B. E. Magun, and L. M. Matrisian. 1992. The role of c-Fos in growth factor regulation of stromelysin/transin gene expression. Matrix Suppl. 1:176-183.
22. Kovary, K., and R. Bravo. 1901. The Jun and Fos protein families are both required for cell cycle progression in fibroblasts. Mol. Cell. Biol. 11:4466-4472.
23. Lazo, P. S., K. Dorfman, T. Noguchi, M.-G. Mattei, and R. Bravo. 1992. Structure and mapping of the fosB gene. FosB downregulates the activity of the fosB promoter. Nucleic Acids Res. 20:343-350.
24. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
25. Miao, G. G., and T. Curran. 1994. Cell transformation by c-fos requires an extended period of expression and is independent of the cell cycle. Mol. Cell. Biol. 14:4295-4310.
26. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131-134.
27. Musgrove, E. A., C. S. L. Lee, M. F. Buckley, and R. L. Sutherland. 1994. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl. Acad. Sci. USA 91:8022-8026.
28. Nigh, E., and M. E. Greenberg. Unpublished results.
29. Nigh, E., F. Sandou, and M. E. Greenberg. Unpublished observations.
30. Nishikura, K., and J. M. Murray. 1987. Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells. Mol. Cell. Biol. 7:639-649.
31. Ofir, R., V. J. Dwarki, D. Rashid, and I. M. Verma. 1990. Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-Fos promoter. Nature 348:80-82.
32. Ohtsubo, M., and J. M. Roberts. 1993. Cyclin-dependent regulation of G1 in mammalian cells. Science 259:1908-1912.
33. Pestell, R. G., A. N. Hollenberg, C. Albanese, and J. L. Ja meson. 1994. c-Jun represses transcription of the human chorionic gonadotropin alpha and beta genes through distinct types of CREs. J. Biol. Chem. 269:31090-31096.
34. Pestell, R. G., and R. J. Lee. Unpublished observations.
35. 1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.
36. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669-1679.
37. Riabowol, K. T. 1988. Microinjection of Fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol. Cell. Biol. 8:1670-1676.
38. Robertson, E. J. (ed.). 1987. Teratocarcinomas and embryonic stem cells: a practical approach. IRL Press, Oxford, United Kingdom.
39. Rudnicki, M. A., P. N. Schnegelsberg, R. H. Stead, T. Braun, H. H. Arnold, and R. Jaenisch. 1993. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75:1351-1359.
40. Ruther, U., W. Muller, T. Sumida, T. Tokuhisa, K. Rajewsky, and E. F. Wagner. 1988. c-fos expression interferes with thymus development in transgenic mice. Cell 53:847-856.
41. Sheng, M., S. T. Dougan, G. McFadden, and M. E. Greenberg. 1988. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol. Cell. Biol. 8:2787-2796.
42. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
43. Sherr, C. J. 1995. D-type cyclins. Trends Biochem. Sci. 20:187-190.
44. Sicinski, P., J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg. 1995. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630.
45. Watanabe, G., A. Howe, R. J. Lee, C. Albanese, I.-W. Shu, A. N. Karnezis, L. Zon, J. Kyriakis, K. Rundell, and R. G. Pestell. 1996. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93:12861-12866.
46. Watanabe, G., R. J. Lee, C. Albanese, W. E. Rainey, D. Batlle, and R. G. Pestell. 1996. Angiotensin II (AII) activation of cyclin D1-dependent kinase activity. J. Biol. Chem. 271:22570-22577.
47. Won, K.-A., Y. Xiong, D. Beach, and M. Z. Gilman. 1992. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc. Natl. Acad. Sci. USA 89:9910-9914.
48. Yen, J., R. M. Wisdom, I. Trainer, and I. M. Verma. 1991. An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc. Natl. Acad. Sci. USA 88:5077-5081.